Related references
Note: Only part of the references are listed.Effects of conditioned media from murine lung cancer cells and human tumor cells on cultured myotubes
Blas A. Guigni et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)
Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia
Rianne D. W. Vaes et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis
Jorne Ubachs et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019
Stephan von Haehling et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells
Jingxuan Yang et al.
GASTROENTEROLOGY (2019)
Percentiles for skeletal muscle index, area and radiation attenuation based on computed tomography imaging in a healthy Caucasian population
A. van der Werf et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2018)
Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naive pancreatic cancer patients
Erin E. Talbert et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia
Fabrizio Pin et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
mTOR and Tumor Cachexia
Adrian P. Duval et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice
Jacob L. Brown et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Sarcopenia in Advanced Serous Ovarian Cancer
Holger Bronger et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling
Kristine Pettersen et al.
SCIENTIFIC REPORTS (2017)
The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery
I. J. G. Rutten et al.
EJSO (2017)
Lewis lung carcinoma regulation of mechanical stretch-induced protein synthesis in cultured myotubes
Song Gao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2016)
Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer
Amanika Kumar et al.
GYNECOLOGIC ONCOLOGY (2016)
Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients
Iris J. G. Rutten et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
Role of Activin A and Myostatin in Human Cancer Cachexia
Audrey Loumaye et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: An in vitro and in vivo study
Lei Yuan et al.
ONCOLOGY REPORTS (2015)
Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer
Stefanie Aust et al.
PLOS ONE (2015)
REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy
Florian A. Britto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia
Serkan Kir et al.
NATURE (2014)
Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research
Nuzhat Ahmed et al.
FRONTIERS IN ONCOLOGY (2013)
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
Emma Kipps et al.
NATURE REVIEWS CANCER (2013)
Pre-cachexia in patients with stages I-III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system
C. M. Op den Kamp et al.
LUNG CANCER (2012)
Malnutrition among gynaecological cancer patients
B. Laky et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2007)
Mechanisms of transcoelomic metastasis in ovarian cancer
David S. P. Tan et al.
LANCET ONCOLOGY (2006)
Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia
J Khal et al.
BRITISH JOURNAL OF CANCER (2005)
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
M Sandri et al.
CELL (2004)
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
J Brugarolas et al.
GENES & DEVELOPMENT (2004)
Malignant ascites: Past, present, and future
RA Adam et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
The IGF-1/PI3K/Akt pathway prevents short article expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors
TN Stitt et al.
MOLECULAR CELL (2004)
Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-κB
RCJ Langen et al.
FASEB JOURNAL (2001)
Cytokines IL-1 beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF alpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel
RT Penson et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2000)
Share Paper
